Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLUTASIDENIB vs OMEPRAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLUTASIDENIB vs OMEPRAZOLE: Safety Overview

Metric OLUTASIDENIB OMEPRAZOLE
Total FAERS Reports 210 87,111
Deaths Reported 27 8,515
Death Rate 12.9% 9.8%
Hospitalizations 85 19,847
Average Patient Age 66.2 yrs 58.7 yrs
% Female Patients 46.3% 58.9%
FDA Approval Date Dec 1, 2022 Apr 17, 2009
Manufacturer Rigel Pharmaceuticals, Inc. Cipla USA Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued